共 50 条
- [1] Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94) [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 104 (02) : 213 - 218
- [2] Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: Ten-year Follow-up of a Randomized Phase III Trial (SAKK 10/94) [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S28 - S28
- [3] CONCOMITANT CISPLATIN AND HYPERFRACTIONATED RADIOTHERAPY IN LOCALLY ADVANCED HEAD-AND-NECK CANCER: 10-YEAR FOLLOW-UP OF A RANDOMIZED PHASE III TRIAL (SAKK 10/94) [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 524 - 531
- [4] Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer [J]. CANCER JOURNAL, 2006, 12 (01): : 63 - 68
- [9] Impact of Weight Loss on Survival After Chemoradiation for Locally Advanced Head and Neck Cancer: Secondary Results of a Randomized Phase 3 Trial (SAKK 10/94) [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S510 - S511